Nitric Oxide, Oxidative Stress, Immune Response and Critical Care

Nitric Oxide

Volumn , Issue , 2010, Pages 755-772

  Napoli, Claudio ^a   Crimi, Ettore ^b   Williams Ignarro, Sharon ^c   Nigris, Filomena de ^d   Ignarro, Louis J ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Division of Anesthesiology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542886     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373866-0.00023-X     Document Type: Chapter

References (170)

1. Adachi T., Weisbrod R.M., Pimentel D.R., Ying J., Sharov V.S., Schöneich C., Cohen R.A. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 2004, 10:1200-1207.
2. Ali M.H., Schumacker P.T. Endothelial responses to mechanical stress: where is the mechanosensor?. Crit. Care Med. 2002, 30:S198-S206.
3. Anggard E. Nitric oxide: mediator, murderer and medicine. Lancet 1994, 343:1199-1206.
4. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
5. Annane D., Sanquer S., Sébille V., Faye A., Djuranovic D., Raphaël J.C., Gajdos P., Bellissant E. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000, 355:1143-1148.
6. Arkovitz M.S., Wispe J.R., Garcia V.F., Szabo C. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J. Pediatr. Surg. 1996, 31:1009-1015.
7. Avontuur J.A., Biewenga M., Buijk S.L., Kanhai K.J., Bruining H.A. Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock, worsening organ dysfunction and increased mortality. Shock 1998, 9:451-454.
8. Avontuur J.A., Tutein Nolthenius R.P., van Bodegom J.W., Bruining H.A. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit. Care Med. 1998, 26:660-667.
9. Awad S.S. State-of-the-art therapy for severe sepsis and multisystem organ dysfunction. Am. J. Surg. 2003, 186:23S-30S.
10. Banda M.A., Lefer D.J., Granger D.N. Postischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice. Am. J. Physiol. 1997, 273:2721-2725.
11. Bateman R.M., Sharpe M.D., Ellis C.G. Bench-to-bedside review: microvascular dysfunction in sepsis - hemodynamics, oxygen transport, and nitric oxide. Crit. Care 2003, 7:359-373.
12. Berkowitz D.E. Myocyte nitroso-redox imbalance in sepsis: NO simple answer. Circ. Res. 2007, 100:1-4.
13. Boczkowski J., Lanone S., Ungureanu-Longrois D., Danialou G., Fournier T., Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats. J. Clin. Invest. 1996, 98:1550-1559.
14. Boczkowski J., Lisdero C.L., Lanone S., Samb A., Carreras M.C., Boveris A., Aubier M., Poderoso J.J. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 1999, 13:1637-1646.
15. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994, 368:850-853.
16. Bultinck J., Sips P., Vakaet L., Brouckaert P., Cauwels A. Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J. 2006, 20:2363-2365.
17. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87:840-844.
18. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
19. Carden D.L., Granger D.N. Pathophysiology of ischaemia-reperfusion injury. Pathophysiology of ischaemia-reperfusion injury. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 2000, 190:255-266.
20. Cauwels A. Nitric oxide in shock. Kidney Int. 2007, 72:557-565.
21. Chapman K.E., Sinclair S.E., Zhuang D., Hassid A., Desai L.P., Waters C.M. Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L834-L841.
22. Chatterjee S., Levitan I., Wei Z., Fisher A.B. KATP channels are an important component of the shear-sensing mechanism in the pulmonary microvasculature. Microcirculation 2006, 13:633-644.
23. Chavez A.M., Menconi M.J., Hodin R.A., Fink M.P. Cytokine-induced intestinal epithelial hyperpermeability: Role of nitric oxide. Crit. Care Med. 1999, 27:2246-2251.
24. Chow C.W., Herrera Abreu M.T., Suzuki T., Downey G.P. Oxidative stress and acute lung injury. Am. J. Respir. Cell. Mol. Biol. 2003, 29:427-431.
25. Cobb J.P., Danner R.L. Nitric oxide and septic shock. JAMA 1996, 275:1192-1196.
26. Cobb J.P., Hotchkiss R.S., Swanson P.E., Chang K., Qiu Y., Laubach V.E., Karl I.E., Buchman T.G. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999, 126:438-442.
27. Cobb J.P., Natanson C., Hoffman W.D., Lodato R.F., Banks S., Koev C.A., Solomon M.A., Elin R.J., Hosseini J.M., Danner R.L. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 1992, 176:1175-1182.
28. Coleman J.W. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 2001, 1:1397-1406.
29. Collins D.M., McCullough W.T., Ellsworth M.L. Conducted vascular responses: communication across the capillary bed. Microvasc. Res. 1998, 56:43-53.
30. Crimi E., Ignarro L.J., Napoli C. Microcirculation and oxidative stress. Free Radic. Res. 2007, 41:1364-1375.
31. Davenpeck K.L., Guo J.P., Lefer A.M. Pulmonary artery endothelial dysfunction following ischemia and reperfusion of the rabbit lung. J. Vasc. Res. 1993, 30:145-153.
32. De Backer D., Creteur J., Preiser J.C., Dubois M.J., Vincent J.L. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 2002, 166:98-104.
33. DeFily D.V. Control of microvascular resistance in physiological conditions and reperfusion. J. Mol. Cell. Cardiol. 1998, 30:2547-2554.
34. Dellinger R.P. Cardiovascular management of septic shock. Crit. Care Med 2003, 31:946-955.
35. Derakhshan B., Hao G., Gross S.S. Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc. Res 2007, 75:210-219.
36. Drazenovic R., Samsel R.W., Wylam M.E., Doerschuk C.M., Schumacker P.T. Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia. J. Appl. Physiol. 1992, 72:259-265.
37. Duranski M.R., Elrod J.W., Calvert J.W., Bryan N.S., Feelisch M., Lefer D.J. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am. J. Physiol. Heart. Circ. Physiol. 2006, 291:H2980-H2986.
38. el-Dwairi Q., Comtois A., Guo Y., Hussain S.N. Endotoxin-induced skeletal muscle contractile dysfunction: contribution of nitric oxide synthases. Am. J. Physiol. 1998, 247:C770-C779.
39. Ellis C.G., Jagger J., Sharpe M. The microcirculation as a functional system. Crit. Care 2005, 9:S3-S8.
40. Eltzschig H.K., Collard C.D. Vascular ischaemia and reperfusion injury. Br. Med. Bull. 2004, 70:71-86.
41. Evans T., Carpenter A., Kinderman H., Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock 1993, 41:77-78.
42. Farquhar I., Martin C.M., Lam C., Potter R., Ellis C.G., Sibbald W.J. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J. Surg. Res. 1996, 61:190-196.
43. Feihl F., Waeber B., Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock?. Pharmacol. Ther. 2001, 91:179-213.
44. Fernandes D., Assreuy J. Nitric oxide and vascular reactivity in sepsis. Shock 2008, 30(Suppl 1):10-13.
45. Fink M.P. Role of reactive oxygen and nitrogen species in acute respiratory distress syndrome. Curr. Opin. Crit. Care 2002, 8:6-11.
46. Fisher A.B., Al-Mehdi A.B., Manevich Y. Shear stress and endothelial cell activation. Crit. Care Med. 2002, 30:S192-S197.
47. Fisher A.B., Chien S., Barakat A.I., Nerem R.M. Endothelial cellular response to altered shear stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L529-L533.
48. Fleming I., Julou-Schaeffer G., Gray G.A., Parratt J.R., Stoclet J.C. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br. J. Pharmacol. 1991, 103:1047-1052.
49. Gath I., Closs E.I., Godtel-Armbrust U., Schmitt S., Nakane M., Wessler I., Forstermann U. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J. 1996, 10:1614-1620.
50. Giusti-Paiva A., De Castro M., Antunes-Rodrigues J., Carnio E.C. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit. Care Med. 2002, 30:1306-1310.
51. Goode H.F., Howdle P.D., Walker B.E., Webster N.R. Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin. Sci. (Lond.) 1995, 88:131-133.
52. Gray G.A., Schott C., Julou-Schaeffer G., Fleming I., Parratt J.R., Stoclet J.C. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br. J. Pharmacol. 1991, 103:1218-1224.
53. Hammerschmidt S., Buchler N., Wahn H. Tissue lipid peroxidation and reduced glutathione depletion in hypochlorite-induced lung injury. Chest 2002, 121:573-581.
54. Hammerschmidt S., Sandvoss T., Gessner C., Schauer J., Wirtz H. High in comparison with low tidal volume ventilation aggravates oxidative stress-induced lung injury. Biochim. Biophys. Acta. 2003, 1637:75-82.
55. Hammerschmidt S., Schiller J., Kuhn H., Meybaum M., Gessner C., Sandvoss T., Arnold K., Wirtz H. Influence of tidal volume on pulmonary NO release, tissue lipid peroxidation and surfactant phospholipids. Biochim. Biophys. Acta. 2003, 1639:17-26.
56. Harris N.R. Opposing effects of L-NAME on capillary filtration rate in the presence or absence of neutrophils. Am. J. Physiol. 1997, 273:1320-1325.
57. Harris N.R., Granger D.N. Neutrophil enhancement of reperfusion-induced capillary fluid filtration associated with hypercholesterolemia. Am. J. Physiol. 1996, 271:1755-1761.
58. Hein T.W., Zhang C., Wang W., Chang C.I., Thengchaisri N., Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J. 2003, 17:2328-12320.
59. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6:150-166.
60. Hickey M.J., Sihota E., Amrani A., Santamaria P., Zbytnuik L.D., Ng E.S., Ho W., Sharkey K.A., Kubes P. Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues. FASEB J. 2002, 16:1141-1143.
61. Hierholzer C., Harbrecht B., Menezes J.M., Kane J., MacMicking J., Nathan C.F., Peitzman A.B., Billiar T.R., Tweardy D.J. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 1998, 187:917-928.
62. Hines I.N., Harada H., Flores S., Gao B., McCord J.M., Grisham M.B. Endothelial nitric oxide synthase protects the post-ischemic liver: potential interactions with superoxide. Biomed. Pharmacother. 2005, 59:183-189.
63. Hofmann F., Feil R., Kleppisch T., Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol. Rev. 2006, 86:1-23.
64. Hollenberg S.M., Easington C.R., Osman J., Broussard M., Parrillo J.E. Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 1999, 12:262-267.
65. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
66. Huang P.L. Lessons learned from nitric oxide synthase knockout animals. Semin. Perinatol. 2000, 24:87-90.
67. Hughes M.N. Chemistry of nitric oxide and related species. Methods. Enzymol. 2008, 436:3-19.
68. Ichinose F., Buys E.S., Neilan T.G., Furutani E.M., Morgan J.G., Jassal D.S., Graveline A.R., Searles R.J., Lim C.C., Kaneki M., Picard M.H., Scherrer-Crosbie M., Janssens S., Liao R., Bloch K.D. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ. Res. 2007, 100:130-139.
69. Ignarro L.J., Balestrieri M.L., Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 2007, 73:326-340.
70. Ignarro L.J., Cirino G., Casini A., Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 1999, 34:879-886.
71. Isobe M., Katsuramaki T., Hirata K., Kimura H., Nagayama M., Matsuno T. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999, 68:803-813.
72. Julou-Schaeffer G., Gray G.A., Fleming I., Schott C., Parratt J.R., Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 1990, 259:H1038-H1043.
73. Kaizu T., Ikeda A., Nakao A., Takahashi Y., Tsung A., Kohmoto J., Toyokawa H., Shao L., Bucher B.T., Tomiyama K., Nalesnik M.A., Murase N., Geller D.A. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 2006, 43:464-473.
74. Kass D.A., Takimoto E., Nagayama T., Champion H.C. Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res. 2007, 75:303-314.
75. Kilbourn R.G., Fonseca G.A., Griffith O.W., Ewer M., Price K., Striegel A., Jones E., Logothetis C.J. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit. Care Med. 1995, 23:1018-1024.
76. Kilbourn R.G., Gross S.S., Jubran A., Adams J., Griffith O.W., Levi R., Lodato R.F. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 1990, 87:3629-3632.
77. Kilbourn R.G., Gross S.S., Lodato R.F., Adams J., Levi R., Miller L.L., Lachman L.B., Griffith O.W. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine. J. Natl. Cancer Inst. 1992, 84:1008-1016.
78. Kilbourn R.G., Jubran A., Gross S.S., Griffith O.W., Levi R., Adams J., Lodato R.F. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 1990, 172:1132-1138.
79. Kimura H., Katsuramaki T., Isobe M., Nagayama M., Meguro M., Kukita K., Nui A., Hirata K. Role of inducible nitric oxide synthase in pig liver transplantation. J. Surg. Res. 2003, 111:28-37.
80. Kinugawa K., Takahashi T., Kohmoto O., Yao A., Aoyagi T., Momomura S., Hirata Y., Serizawa T. Nitric oxide-mediated effects of interleukin-6 on [Ca 2+] and cell contraction in cultured chick ventricular myocytes. Circ. Res. 1994, 75:285-295.
81. Kirkebøen K.A., Strand O.A. The role of nitric oxide in sepsis - an overview. Acta. Anaesthesiol. Scand. 1999, 43:275-288.
82. Klabunde R.E., Ritger R.C. NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem. Biophys. Res. Commun. 1991, 178:1135-1140.
83. Klijn E., Den Uil C.A., Bakker J., Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med. 2008, 29:643-654.
84. Koeppel T.A., Mihaljevic N., Kraenzlin B., Loehr M., Jesenofsky R., Post S., Palma P. Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur. Surg. Res. 2007, 39:303-311.
85. Kooy N.W., Royall J.A., Ye Y.Z., Kelly D.R., Beckman J.S. Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med. 1995, 151:1250-1254.
86. Kristof A.S., Goldberg P., Laubach V., Hussain S.N. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 1998, 158:1883-1889.
87. Kumar A., Brar R., Wang P., Dee L., Skorupa G., Khadour F., Schulz R., Parrillo J.E. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 1999, 276:R265-R276.
88. Kuzkaya N., Weissmann N., Harrison D.G., Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 2003, 278:22546-22554.
89. Lam C., Tyml K., Martin C., Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J. Clin. Invest. 1994, 94:2077-2083.
90. Lamb N.J., Gutteridge J.M., Baker C., Evans T.W., Quinlan G.J. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit. Care Med. 1999, 27:1738-1744.
91. Lehr H.A., Bittinger F., Kirkpatrick C.J. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?. J. Pathol. 2000, 190:373-386.
92. Levy R.M., Prince J.M., Billiar T.R. Nitric oxide: a clinical primer. Crit. Care Med. 2005, 33:S492-S495.
93. Liaudet L., Rosselet A., Schaller M.D., Markert M., Perret C., Feihl F. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J. Infect. Dis. 1998, 177:127-132.
94. Liaudet L., Soriano F.G., Szabó C. Biology of nitric oxide signaling. Crit. Care Med. 2000, 28:N37-N52.
95. Liaudet L., Soriano F.G., Szabó E., Virág L., Mabley J.G., Salzman A.L., Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc. Natl. Acad. Sci. USA 2000, 97:10203-10208.
96. Liu L., Hausladen A., Zeng M., Que L., Heitman J., Stamler J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 2001, 410:490-494.
97. Liu L., Yan Y., Zeng M., Zhang J., Hanes M.A., Ahearn G., McMahon T.J., Dickfeld T., Marshall H.E., Que L.G., Stamler J.S. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004, 116:617-628.
98. Liu S., Adcock I.M., Old R.W., Barnes P.J., Evans T.W. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 1993, 196:1208-1213.
99. López A., Lorente J.A., Steingrub J., Bakker J., McLuckie A., Willatts S., Brockway M., Anzueto A., Holzapfel L., Breen D., Silverman M.S., Takala J., Donaldson J., Arneson C., Grove G., Grossman S., Grover R. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 2004, 32:21-30.
100. Martínez-Ruiz A., Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc. Res. 2007, 75:220-228.
101. Matsuo N. The role of intrapulmonary nitric oxide generation in the development of adult respiratory distress syndrome. Surg. Today 1999, 29:1068-1074.
102. Meguro M., Katsuramaki T., Nagayama M., Kimura H., Isobe M., Kimura Y., Matsuno T., Nui A., Hirata K. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation 2002, 73:1439-1446.
103. Meredith I.T., Currie K.E., Anderson T.J., Roddy M.A., Ganz P., Creager M.A. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am. J. Physiol. 1996, 270:1435-1440.
104. Mikawa K., Nishina K., Tamada M., Takao Y., Maekawa N., Obara H. Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit. Care Med. 1998, 26:905-911.
105. Moncada S., Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 2006, 147(Suppl 1):S193-S201.
106. Mota-Filipe H., McDonald M.C., Cuzzocrea S., Thiemermann C. A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 1999, 12:255-261.
107. Napoli C., de Nigris F., Palinski W. Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 2001, 82:674-682.
108. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 2006, 15:265-279.
109. Napoli C., Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide 2001, 5:88-97.
110. Napoli C., Ignarro L.J. Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol. 2003, 43:97-123.
111. Nava E., Palmer R.M., Moncada S. The role of nitric oxide in endotoxic shock: effects of NG-monomethyl-L-arginine. J. Cardiovasc. Pharmacol. 1992, 20:S132-S134.
112. Nishida T., Yu J.D., Minamishima S., Sips P.Y., Searles R.J., Buys E.S., Janssens S., Brouckaert P., Bloch K.D., Ichinose F. Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice. Crit. Care Med. 2009, 37:256-262.
113. Ochoa J.B., Udekwu A.O., Billiar T.R., Curran R.D., Cerra F.B., Simmons R.L., Peitzman A.B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991, 214:621-626.
114. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
115. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991, 338:1557-1558.
116. Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 1994, 28:34-39.
117. Piper R.D., Pitt-Hyde M., Li F., Sibbald W.J., Potter R.F. Microcirculatory changes in rat skeletal muscle in sepsis. Am. J. Respir. Crit. Care Med. 1996, 154:931-937.
118. Preiser J.C., Lejeune P., Roman A., Carlier E., De Backer D., Leeman M., Kahn R.J., Vincent J.L. Methylene blue administration in septic shock: a clinical trial. Crit. Care Med. 1995, 23:259-264.
119. Reffelmann T., Hale S.L., Dow J.S., Kloner R.A. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003, 108:2911-2917.
120. Resnick N., Yahav H., Schubert S., Wolfovitz E., Shay A. Signalling pathways in vascular endothelium activated by shear stress: relevance to atherosclerosis. Curr. Opin. Lipidol. 2000, 11:167-177.
121. Revelly J.P., Ayuse T., Brienza N., Fessler H.E., Robotham J.L. Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit. Care Med. 1996, 24:1345-1351.
122. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M. Early Goal-Directed Therapy Collaborative Group. N. Engl. J. Med. 2001, 345:1368-1377.
123. Rudiger A., Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit. Care Med. 2007, 35:1599-1608.
124. Saetre T., Hoiby E.A., Aspelin T., Lermark G., Egeland T., Lyberg T. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit. Care Med. 2000, 28:2697-2706.
125. Salvemini D., Korbut R., Anggård E., Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:2593-2597. [published erratum in: Proc Natl Acad Sci U S A 1990;87:6007.].
126. Salvo I., de Cian W., Musicco M., Langer M., Piadena R., Wolfler A., Montani C., Magni E. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med. 1995, 21:S244-S249.
127. Sanders K.A., Huecksteadt T., Xu P., Sturrock A.B., Hoidal J.R. Regulation of oxidant production in acute lung injury. Chest 1999, 116:56S-61S.
128. Schumacker P.T., Kazaglis J., Connolly H.V., Samsel R.W., O'Connor M.F., Umans J.G. Systemic and gut O2 extraction during endotoxemia. Role of nitric oxide synthesis. Am. J. Respir. Crit. Care Med. 1995, 151:107-115.
129. Schwartz D., Mendonca M., Schwartz I., Xia Y., Satriano J., Wilson C.B., Blantz R.C. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J. Clin. Invest. 1997, 100:439-448.
130. Serracino-Inglott F., Virlos I.T., Habib N.A., Williamson R.C., Mathie R.T. Differential nitric oxide synthase expression during hepatic ischemia-reperfusion. Am. J. Surg. 2003, 185:589-595.
131. Shanley T.P., Zhao B., Macariola D.R., Denenberg A., Salzman A.L., Ward P.A. Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit. Care Med. 2002, 30:1960-1968.
132. Shultz P.J., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 1992, 90:1718-1725.
133. Sittipunt C., Steinberg K.P., Ruzinski J.T., Myles C., Zhu S., Goodman R.B., Hudson L.D., Matalon S., Martin T.R. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 163:503-510.
134. Stauton M., Drexler C., Dulitz M.G., Ekbom D.C., Schmeling W.T., Farber N.E. Effects of hypoxia-reoxygenation on microvascular endothelial function in the rat hippocampal slice. Anesthesiology 1999, 91:1462-1469.
135. Stein B., Frank P., Schmitz W., Scholz H., Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J. Mol. Cell Cardiol. 1996, 28:1631-1639.
136. Sternbergh W.C., Makhoul R.G., Adelman B. Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity. Surgery 1993, 114:960-967.
137. Stewart D.J., Pohl U., Bassenge E. Free radicals inhibit endothelium-dependent dilation in the coronary resistance bed. Am. J. Physiol. 1988, 255:H765-H769.
138. Strunk V., Hahnenkamp K., Schneuing M., Fischer L.G., Rich G.F. Selective iNOS inhibition prevents hypothension in septic rats while preserving endothelium-dependent vasodilation. Anesth. Analg. 2001, 92:681-682.
139. Stuehr D.J., Cho H.J., Kwon N.S., Weise M.F., Nathan C.F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA. 1991, 88:7773-7777.
140. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 1985, 82:7738-7742.
141. Suzuki Y., Deitch E.A., Mishima S., Lu Q., Xu D. Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury. Crit. Care Med. 2000, 28:3692-3696.
142. Szabó A., Hake P., Salzman A.L., Szabó C. Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit. Care Med. 1999, 27:1343-1350.
143. Szabó C. Potential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 1998, 9:341-344.
144. Szabó C., Bryk R., Zingarelli B., Southan G.J., Gahman T.C., Bhat V., Salzman A.L., Wolff D.J. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br. J. Pharmacol. 1996, 118:1568-1659.
145. Szabó C., Salzman A.L., Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 1995, 372:229-232.
146. Szabó C., Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 1994, 2:145-155.
147. Takakura K., Taniguchi T., Muramatsu I., Takeuchi K., Fukuda S. Modification of alpha1 -adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit. Care Med. 2002, 30:894-899.
148. Teale D.M., Atkinson A.M. L-canavanine restores blood pressure in a rat model of endotoxic shock. Eur. J. Pharmacol. 1994, 271:87-92.
149. Theruvath T.P., Zhong Z., Currin R.T., Ramshesh V.K., Lemasters J.J. Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: Role of vasodilatory and innate immunity pathways. Transplant. Proc. 2006, 38:3351-3357.
150. Thiemermann C., Szabó C., Mitchell J.A., Vane J.R. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. USA 1993, 90:267-271.
151. Thiemermann C., Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 1990, 182:591-595.
152. Tiefenbacher C.P., Chilian W.M., Mitchell M., DeFily D.V. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation 1996, 94:1423-1429.
153. Tritto I., Ambrosio G. Spotlight on microcirculation: an update. Cardiovasc. Res. 1999, 42:600-606.
154. Trzeciak S., Cinel I., Phillip Dellinger R., Shapiro N.I., Arnold R.C., Parrillo J.E., Hollenberg S.M. Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators. Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad. Emerg. Med. 2008, 15:399-413.
155. Tsuchihashi S., Kaldas F., Chida N., Sudo Y., Tamura K., Zhai Y., Qiao B., Busuttil R.W., Kupiec-Weglinski J.W. FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am. J. Transplant. 2006, 6:2013-2022.
156. Tsukada K., Hasegawa T., Tsutsumi S., Katoh H., Kuwano H., Miyazaki T., Yamamoto Y. Effect of uric acid on liver injury during hemorrhagic shock. Surgery 2000, 127:439-446.
157. Tsukahara Y., Morisaki T., Horita Y., Torisu M., Tanaka M. Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients. World J. Surg. 1998, 22:771-777.
158. Ullrich R., Scherrer-Crosbie M., Bloch K.D., Ichinose F., Nakajima H., Picard M.H., Zapol W.M., Quezado Z.M. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 2000, 102:1440-1446.
159. Umans J.G., Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 1995, 57:771-790.
160. Umans J.G., Samsel R.W. L-canavanine selectively augments contraction in aortas from endotoxemic rats. Eur. J. Pharmacol. 1992, 210:343-346.
161. Umans J.G., Wylam M.E., Samsel R.W., Edwards J., Schumacker P.T. Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta. Am. Rev. Respir. Dis. 1993, 148:1638-1645.
162. Vardanian A.J., Busuttil R.W., Kupiec-Weglinski J.W. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol. Med. 2008, 14:337-345.
163. Verma S., Maitland A., Weisel R.D., Fedak P.W., Pomroy N.C., Li S.H., Mickle D.A., Li R.K., Rao V. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J. Thorac. Cardiovasc. Surg. 2002, 123:1074-1083.
164. Wang W., Suzuki Y., Tanigaki T., Rank D.R., Raffin T.A. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs.
165. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342:1334-1349.
166. Wu F., Wilson J.X., Tyml K. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic. Biol. Med. 2004, 37:1282-1289.
167. Yang C., Moriuchi H., Takase J., Ishitsuka Y., Irikura M., Irie T. Oxidative stress in early stage of acute lung injury induced with oleic acid in guinea pigs. Biol. Pharm. Bull. 2003, 26:424-428.
168. Zhou C., Wu S. T-type calcium channels in pulmonary endothelium. Microcirculation 2006, 13:645-656.
169. Zhu S., Ware L.B., Geiser T., Matthay M.A., Matalon S. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am. J. Respir. Crit. Care Med. 2001, 163:166-172.
170. Zingarelli B., Ischiropoulos H., Salzman A.L., Szabó C. Amelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat. Eur. J. Pharmacol. 1997, 338:55-65.